Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Development and validation of CNN-MLP models for predicting anti-VEGF therapy outcomes in diabetic macular edema ; volume:14 ; number:1 ; day:4 ; month:12 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.12.2024), 1-9, 12.2024
- Classification
-
Ingenieurwissenschaften und Maschinenbau
- Creator
-
Leng, Xiangjie
Shi, Ruijie
Xu, Zhaorui
Zhang, Hai
Xu, Wenxuan
Zhu, Keyin
Lu, Xuejing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-82007-4
- URN
-
urn:nbn:de:101:1-2502182123581.400292263420
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leng, Xiangjie
- Shi, Ruijie
- Xu, Zhaorui
- Zhang, Hai
- Xu, Wenxuan
- Zhu, Keyin
- Lu, Xuejing
- SpringerLink (Online service)
Other Objects (12)
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Anti-VEGF for the management of diabetic macular edema
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema
Effect of intraocular anti-VEGF on cystoid macular edema associated with Henoch-Schonlein purpura-a case report
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection